Mazdutide is an innovative, once-weekly injectable dual-receptor co-agonist designed to activate both the GLP-1 and glucagon receptors simultaneously
Whats on the Horizon: Newer Weight Loss Medications The pace of development of new weight loss drugs has only increased since GLP-1s became available, and two in particular are worth watching
How weight loss injectables work Medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) mimic hormones that help regulate appetite, blood sugar and digestion
The transition to oral medication is not without its challenges, but the potential for increased patient adherence makes it a worthwhile pursuit
Dosage Guidelines Whats Actually Used Important: Neither peptide is approved for human therapeutic use in most countries
All product details, ingredient information, pricing, and policy terms described in this article reflect publicly available information from the product website and labeling